作为GPR40激动剂的文卡明在治疗女性阿尔茨海默病的治疗中显示出潜在的潜力
Jianlu Lyu1, Danyang Zhu2, Ze Wang3
1School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210000, China.
概括
这项研究表明,ERβ/GPR40轴对女性阿尔茨海默病 (AD) 具有至关重要的作用. 文卡明 (Vin) 通过准这一轴来改善认知缺陷和AD病理学,显示出治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 女性患阿尔茨海默氏病 (AD) 的风险更高,这与雌激素损失有关.
- ERβ/GPR40轴为AD提供了潜在的治疗标,避免了ERα风险.
- 温卡明 (Vin) 是一种GPR40激动剂,研究了它在这个轴上的作用.
研究的目的:
- 阐明ERβ/GPR40轴在AD病变发生过程中的作用.
- 研究Vincamine在改善AD相关缺陷方面的治疗潜力.
主要方法:
- 分析了女性AD患者和3×Tg-AD小鼠对ERβ/GPR40表达的临床数据.
- 使用CUT&Tag,对接和分子动力学模拟来研究ERβ-GPR40结合.
- 在AD模型中评估了芬卡明的疗效和潜在机制,包括GPR40敲击.
主要成果:
- 在女性AD大脑中,ERβ和GPR40的下调.
- ERβ直接与GPR40促进体结合;GPR40的敲击会影响认知.
- 文卡明通过抑制神经炎症,抑制高酸化,并通过GPR40通路促进突触可塑性来改善AD病理.
结论:
- 在GPR40促进体中确定了特定的ERβ结合区域和残留物,揭示了新的转录调节机制.
- 确定了ERβ/GPR40轴作为女性AD的潜在治疗策略.
- 突出了芬卡明作为治疗女性阿尔茨海默症的药物的潜力.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在ERβ/GPR40轴上在NLRP3中,NLRP3是NLRP3中的一个.性差异性差异性差异性差异性差异性差异性差异性的过酸化是一种超酸化.文卡明 (Vincamine) 是一种更多相关视频
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...